Holds 2 active US DMFs and one valid CEP for riociguat, filing since 2016. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 4 markets.
Holds one active US DMF and 2 valid CEPs for riociguat, filing since 2017. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 18 markets.
Holds 2 valid CEPs for riociguat, filing since 2026. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 20 markets.
Holds one active US DMF for riociguat, filing since 2025. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 2 markets.
Holds one active US DMF for riociguat, filing since 2025. Its 2019 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Registered with SFDA (Saudi Arabia) for riociguat. Its GMP is recognised in 8 markets.
Holds 2 active US DMFs for riociguat, filing since 2025.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Chat with Fred, your AI analystThe order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for riociguat and what filings they hold.
Chat with Fred, your AI analyst